Edition:
United States

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

12.34USD
20 Apr 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$12.34
Open
$12.32
Day's High
$12.38
Day's Low
$12.09
Volume
133,158
Avg. Vol
266,376
52-wk High
$28.49
52-wk Low
$11.12

Chart for

About

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The... (more)

Overall

Beta: 2.98
Market Cap(Mil.): $403.40
Shares Outstanding(Mil.): 32.69
Dividend: --
Yield (%): --

Financials

  CARA.OQ Industry Sector
P/E (TTM): -- 188.22 33.60
EPS (TTM): -1.12 -- --
ROI: -45.76 -0.74 13.19
ROE: -46.85 -2.80 15.00

BRIEF-Cara Therapeutics Reports Q4 Loss Per Share $0.43

* CARA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 15 2018

BRIEF-Cara Therapeutics Inc reports Q3 loss per share $0.38

* Cara Therapeutics Inc reports third quarter 2017 financial results

Nov 02 2017

Earnings vs. Estimates